Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphological, physiological, and biochemical changes in rhodopsin knockout mice

J Lem1, N V Krasnoperova, P D Calvert

  • 1New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA. jlem01@tuffs.edu

Proceedings of the National Academy of Sciences of the United States of America
|January 20, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts.

European journal of ophthalmology·2022
Same author

Variation in chemotherapy prescribing rates and mortality in early breast cancer over two decades: a national data linkage study.

ESMO open·2021
Same author

Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Razumab -- the role of biosimilars for the treatment of retinal diseases.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

An update on conbercept to treat wet age-related macular degeneration.

Drugs of today (Barcelona, Spain : 1998)·2020

Rod opsin gene mutations cause inherited retinal degenerations. Reducing opsin levels in mice caused photoreceptor degeneration, revealing insights into vision loss mechanisms.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in rod opsin, a key protein in rod photoreceptors, are responsible for about 15% of inherited human retinal degenerations.
  • The precise physiological and molecular mechanisms driving these diseases remain incompletely understood.
  • Studying transgenic mice with mutated opsin genes is a common approach, but opsin overexpression can cause photoreceptor degeneration.

Purpose of the Study:

  • To investigate the role of rod opsin levels in photoreceptor health and degeneration.
  • To overcome limitations of overexpression models by reducing or eliminating endogenous opsin.
  • To elucidate the physiological consequences of reduced rhodopsin levels.

Main Methods:

  • Targeted gene disruption was used to create mice lacking one or both rod opsin alleles.

Related Experiment Videos

  • Retinal development and photoreceptor integrity were assessed in these genetically modified mice.
  • Physiological and biochemical analyses were performed on retinas with reduced opsin content.

    • Main Results:

    • Mice lacking both opsin alleles showed failed outer segment formation and complete photoreceptor degeneration.
    • Mice with a single opsin allele developed normally but had reduced rhodopsin and slower degeneration.
    • Reduced opsin levels resulted in decreased light sensitivity, altered flash-response kinetics, and increased phosducin.

    Conclusions:

    • Rod opsin levels are critical for photoreceptor outer segment development and survival.
    • Partial reduction of opsin leads to functional deficits and a slower degeneration time course.
    • These findings provide insights into the pathogenesis of inherited retinal degenerations linked to opsin mutations.